# A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT

> **NCT00477542** · PHASE1 · COMPLETED · sponsor: **Indiana University** · enrollment: 18 (actual)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **DRUG:** clofarabine

## Key facts

- **NCT ID:** NCT00477542
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477542, "A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00477542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*